Heng Weng

458 total citations
22 papers, 141 citations indexed

About

Heng Weng is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Heng Weng has authored 22 papers receiving a total of 141 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 7 papers in Infectious Diseases and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Heng Weng's work include Influenza Virus Research Studies (4 papers), Respiratory viral infections research (4 papers) and Antifungal resistance and susceptibility (4 papers). Heng Weng is often cited by papers focused on Influenza Virus Research Studies (4 papers), Respiratory viral infections research (4 papers) and Antifungal resistance and susceptibility (4 papers). Heng Weng collaborates with scholars based in China, United States and Israel. Heng Weng's co-authors include Xinhang Wang, Jinbao Huang, Hongyan Li, Lulu Wang, Hongying Zhang, Lulu Chen, Hui Ye, Guihua Xu, Shuxing Chen and Hongyan Li and has published in prestigious journals such as Frontiers in Microbiology, Medicine and Frontiers in Endocrinology.

In The Last Decade

Heng Weng

19 papers receiving 141 citations

Peers

Heng Weng
Euri Seo South Korea
Renaud Cezar France
Deepak Nagra United Kingdom
Ayelet Ollech Israel
Marko Barešić Croatia
Nida Dinçel Türkiye
Muhammad B. Hammami United States
Beata Klincewicz Poland
S. Trouillier France
Fred Ghali United States
Euri Seo South Korea
Heng Weng
Citations per year, relative to Heng Weng Heng Weng (= 1×) peers Euri Seo

Countries citing papers authored by Heng Weng

Since Specialization
Citations

This map shows the geographic impact of Heng Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng Weng more than expected).

Fields of papers citing papers by Heng Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heng Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng Weng. The network helps show where Heng Weng may publish in the future.

Co-authorship network of co-authors of Heng Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Heng Weng. A scholar is included among the top collaborators of Heng Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heng Weng. Heng Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Weng, Heng, et al.. (2024). Bronchoalveolar lavage fluid and lung biopsy tissue metagenomic next-generation sequencing in the diagnosis of pulmonary cryptococcosis. Frontiers in Cellular and Infection Microbiology. 14. 1446814–1446814. 1 indexed citations
4.
5.
Wang, Qing K., Heng Weng, Yue Xu, et al.. (2023). Anti-osteoporosis mechanism of resistance exercise in ovariectomized rats based on transcriptome analysis: a pilot study. Frontiers in Endocrinology. 14. 1162415–1162415. 5 indexed citations
6.
7.
Weng, Heng, et al.. (2023). Clinical Application and Evaluation of Metagenomic Next-Generation Sequencing for Lower Respiratory Tract Infections and Human Tumor Screening. International Journal of General Medicine. Volume 16. 5763–5777. 3 indexed citations
8.
9.
Ye, Hui, et al.. (2022). Effectiveness and safety of aerobic exercise for rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials. BMC Sports Science Medicine and Rehabilitation. 14(1). 17–17. 28 indexed citations
10.
Weng, Heng, et al.. (2022). Moxibustion for diarrhea-predominant irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Clinical Practice. 46. 101532–101532. 4 indexed citations
11.
Weng, Heng, et al.. (2022). Convalescent plasma therapy for patients with severe COVID-19: A case series study. Medicine. 101(31). e29912–e29912.
12.
Huang, Jinbao, et al.. (2020). Diagnostic and prognostic predictive values of circulating KL-6 for interstitial lung disease. Medicine. 99(16). e19493–e19493. 16 indexed citations
13.
Li, Hongyan, et al.. (2019). Concomitant lung adenocarcinoma and pulmonary cryptococcosis confirmed by pathologic examinations. Medicine. 98(50). e18316–e18316. 9 indexed citations
14.
Li, Hongyan, Heng Weng, Hongying Zhang, et al.. (2018). Comparison of patients with avian influenza A (H7N9) and influenza A (H1N1) complicated by acute respiratory distress syndrome. Medicine. 97(12). e0194–e0194. 30 indexed citations
15.
Lan, Chao, et al.. (2017). [Clinical application and evaluation of an early non-sedation protocol for critically ill respiratory patients].. PubMed. 40(3). 188–192. 1 indexed citations
16.
Chen, Lulu, et al.. (2017). Potential killer in the ICU—severe tuberculosis combined with hemophagocytic syndrome. Medicine. 96(49). e9142–e9142. 6 indexed citations
17.
Li, Hongyan, et al.. (2016). Clinical analysis of 13 severe cases of influenza A (H7N9) virus infection. 9(4). 363–366. 1 indexed citations
18.
Liu, Jiafu, et al.. (2015). Histopathological findings in a critically ill patient with avian influenza A (H7N9).. PubMed. 7(12). E672–7. 11 indexed citations
19.
Zhou, Caicun, et al.. (2014). Once-daily, oral levofloxacin monotherapy for low-risk neutropenic fever in cancer patients. Anti-Cancer Drugs. 26(3). 359–362. 4 indexed citations
20.
Chen, Yusheng, et al.. (2010). [Clinical features of 127 cases of novel influenza A (H1N1) infection in Fujian Province].. PubMed. 33(2). 81–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Euri Seo Breakdown of academic impact, for papers by Renaud Cezar Breakdown of academic impact, for papers by Deepak Nagra Breakdown of academic impact, for papers by Ayelet Ollech Breakdown of academic impact, for papers by Marko Barešić Breakdown of academic impact, for papers by Nida Dinçel Breakdown of academic impact, for papers by Muhammad B. Hammami Breakdown of academic impact, for papers by Beata Klincewicz Breakdown of academic impact, for papers by S. Trouillier Breakdown of academic impact, for papers by Fred Ghali
Rankless by CCL
2026